Health Industry News
Aussies & Kiwis with incurable blood cancer receive newly subsidised treatment option
Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…
Read MoreDecline in vaccine preventable diseases
The Australian Institute of Health and Welfare (AIHW) has recently released a report detailing results from the Burden of Vaccine Preventable Diseases in Australia study. The study revealed that between 2005 and 2015 the overall rate of vaccine preventable disease (VPD) burden decreased by 31%, demonstrating the value of vaccines. Results from the AIHW study…
Read MoreMovember: Let’s have a look at Men’s Health
Throughout November, you have probably noticed more men than usual flaunting a little bit of hair above their upper lip. It’s no coincidence that every second person looks like Charlie Chaplin, nor is it by chance that many NSW State Transit buses have a prominent black moustache on their fronts. This month is Movember, a…
Read MoreWorld Diabetes Day 2019
Today (November 14) is World Diabetes Day (WDD), the world’s largest diabetes awareness campaign reaching a global audience of over 1 billion people in more than 160 countries. Diabetes is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make sufficient use of the…
Read MoreMedicines safety now a national health priority
Last week, from October 31 to November 1 2019, health ministers from the Commonwealth, New Zealand and each State and Territory of Australia met in Perth for the COAG Health Council Meeting to discuss a range of pressing national health issues. The meeting was chaired by the Western Australian Minister for Health and Mental Health,…
Read More